Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study. - Wikidata - awgldk - TriplyDB

Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.

Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.

http://www.wikidata.org/entity/Q34774357

about

Candidate genes for COPD: current evidence and research Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality Biomarkers of progression of chronic obstructive pulmonary disease (COPD)RAGE: a new frontier in chronic airways disease S100A12 is up-regulated in pulmonary tuberculosis and predicts the extent of alveolar infiltration on chest radiography: an observational study Soluble receptor for advanced glycation end-products and progression of airway disease Soluble receptor for advanced glycation end products predicts 28-day mortality in critically ill patients with sepsis Evaluation of circulating sRAGE in osteoporosis according to BMI, adipokines and fracture risk: a pilot observational study.The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes.The receptor for advanced glycation end products (RAGE) affects T cell differentiation in OVA induced asthma.The receptor for advanced glycation end products (RAGE) contributes to the progression of emphysema in mice One-year prognosis and the role of brain natriuretic peptide levels in patients with chronic cor pulmonale Increased Transcript Complexity in Genes Associated with Chronic Obstructive Pulmonary Disease Soluble RAGEs - Prospects for treating & tracking metabolic and inflammatory disease The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro.Survival in COPD: impact of lung dysfunction and comorbidities.Is hypercapnia associated with poor prognosis in chronic obstructive pulmonary disease? A long-term follow-up cohort study.Advanced glycation endproducts and their receptor in different body compartments in COPD Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.Effect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice.Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD.Association of polymorphisms of the receptor for advanced glycation end products gene with COPD in the Chinese population.Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.DAMPs activating innate and adaptive immune responses in COPD.Asthma and COPD proteomics: current approaches and future directions.Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung.Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokers Role of Inflammation and Oxidative Stress in the Pathology of Ageing in COPD: Potential Therapeutic Interventions.All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses.Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease.Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD.Luteolin alleviates methylglyoxal-induced cytotoxicity in osteoblastic MC3T3-E1 cells.Emphysema requires the receptor for advanced glycation end-products triggering on structural cells.A Pilot Study Linking Endothelial Injury in Lungs and Kidneys in Chronic Obstructive Pulmonary Disease.COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? (2017 Grover Conference Series).Overexpression of RAGE contributes to cigarette smoke-induced nitric oxide generation in COPD.Decreased plasma sRAGE levels in COPD: influence of oxygen therapy

P2860

Q26777324-20BCF445-A3B5-4423-8E14-470F428ACC9E Q26859793-71F25915-D822-4859-A7B4-DA1B8F36DB46 Q26996356-C42B9AA3-1A9C-4497-8693-13AB59F70DBF Q27025295-DC025FAF-6220-41DE-9236-ED454502045A Q28387007-D0111F31-9341-45AB-91E8-490EDB8F6239 Q33613288-73D96BE9-534C-4DE9-9532-03EE15736608 Q33709127-00AAF12D-B410-4818-B3FC-A32F27F4EB40 Q33801160-E221383F-3C03-4C9A-9FED-53FAE9E19D87 Q34346490-2F834D9D-E250-4A81-AB7B-285940680787 Q35156139-ADAF15E2-B5A9-4586-99FC-CADB51474EA2 Q35190905-E0F9D0B8-1CCB-4556-8383-9A094AC89F06 Q35198572-F52C54D6-E997-432F-AA23-D57B52E378B9 Q35812803-E6D14B34-502E-45D1-A51F-4C20167065C4 Q35991574-5B6EAC4D-1CB3-43C4-A7CF-A6A74888A255 Q36166108-E18BC1E2-001C-466E-A671-2795A587054F Q36193333-C482D66C-E447-4426-96C3-89497567966B Q36374199-53BE66BE-F8FC-48F3-86E3-F75F3EBD8F8D Q36842527-F062875B-033C-4CCB-AC70-31F4CC3FC63E Q37066630-5A006558-99B6-4CCA-9157-6AD4B780C12B Q37404091-44A0DB96-5D42-4EFE-B11B-E2961C3291B2 Q37620204-193A0E6F-3E92-4324-BE68-7F2A5973C90C Q37667568-1D4C0A06-19B7-4A52-B2A5-A8E43DD57E42 Q38009797-32596C82-BFD4-487F-9413-30A2C1438406 Q38154796-EB20488A-7876-4C85-B15A-015ECA50C9DB Q38287694-58BA445B-4FB5-477D-8D08-1BE588513C71 Q38541559-BADF8461-C038-45DB-AB72-C43E42AD070D Q38661408-F8F3CBE5-4D5E-41D2-84E0-7AD77BF31E4A Q38953736-0EBDB362-6872-47E4-ACED-685BD12F9EA9 Q39246681-4E43E1C5-97EA-404A-B166-5C3E19CC4521 Q43779676-40C83CB5-D72D-4B94-ADC4-706170094E1E Q44504391-F2BA33DB-C57C-4BEF-9C23-2056EE22B2D8 Q44691601-108A2C33-5067-4937-9EEC-BEF6D1C09338 Q46188793-0B459220-7940-4E3C-A111-DC78634DEFD4 Q47998588-9DBB3EA1-47AB-442D-A51A-6EEBF684652A Q52731057-332EF5E5-1BA7-4374-885F-4112D757B34F Q53066000-F5CDE7B5-AF16-4A31-A4A8-B5CD7A6F9502 Q57549422-71FF38C9-1F9F-48BF-9330-3480DD29CB42

P2860

Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.

http://www.wikidata.org/entity/Q34774357

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Soluble receptor for advanced ...... lmonale: a case-control study.

@ast

Soluble receptor for advanced ...... lmonale: a case-control study.

@en

Soluble receptor for advanced ...... lmonale: a case-control study.

@nl

type

label

Soluble receptor for advanced ...... lmonale: a case-control study.

@ast

Soluble receptor for advanced ...... lmonale: a case-control study.

@en

Soluble receptor for advanced ...... lmonale: a case-control study.

@nl

prefLabel

Soluble receptor for advanced ...... lmonale: a case-control study.

@ast

Soluble receptor for advanced ...... lmonale: a case-control study.

@en

Soluble receptor for advanced ...... lmonale: a case-control study.

@nl

P1433

Q34774357-5330E97E-C025-416C-BE1D-59F238CBE15D

P1476

Q34774357-C6EF17C9-1887-4812-BB32-2148AA295337

P2093

Q34774357-0760B249-7692-4CA0-8100-302795B614FC

Q34774357-14D29E33-2843-4F4A-99AD-5D6DD49809F4

Q34774357-B61C3400-B8FA-4A82-937C-AC00AB5C1FCE

P2860

Q34774357-001CBC87-A146-4AD6-9354-AB09E54F8766

Q34774357-04CC751C-F588-4A3C-947E-82A9A1B22270

Q34774357-17A82EE8-B53A-43F7-9C16-3D6CF570B32E

Q34774357-1A1A1376-B4D2-448E-A4D8-1363EB155608

Q34774357-2214A5BD-F544-4957-B398-00995C1BD0A4

Q34774357-26418E8A-F621-4FD0-8EB6-FDD3526640DA

Q34774357-3EF45363-6015-498D-BB0E-1255E3B093CF

Q34774357-4658DB95-2A66-46FE-8DF9-D91DB2E4F17C

Q34774357-4C2786EC-FD91-4904-B9C9-295718E77D0D

Q34774357-4F939696-8CD0-4196-B912-938FF64209E5

P2888

Q34774357-AF483967-248A-426F-A7C2-E32DFA29DDFC

P304

Q34774357-80DA6103-54B4-4581-BFF2-D6E65440838A

P31

Q34774357-F49378DA-7233-4A5B-A766-B674C85E3607

P356

Q34774357-D0DD922A-994B-451A-834F-4C61C22C5889

P478

Q34774357-8AC797CE-8746-477D-83D7-599BF2CC4D73

P50

Q34774357-198D05C0-4D45-4858-9475-D7FD3F737D3D

Q34774357-3362105B-EEC2-47A2-A7C7-9D9659C0419E

Q34774357-584E939E-EA40-4570-AD1E-A087ECEA405E

P577

Q34774357-BAF24319-1344-4B9F-982A-EAB3AE735521

P5875

Q34774357-C736664A-A446-4F3E-AEA5-D191F3461617

P6179

Q34774357-67B7C41C-52F1-4E87-ADCC-D606B7BACE34

P698

Q34774357-915ABF25-AD84-41A9-B3D5-51D98551E3FF

P921

Q34774357-050C794F-AB94-4055-8E80-B9FA2B5D4033

P932

Q34774357-47530B98-E064-4844-A056-B492BC09333A

P356

1465-9921-12-37

P1433

Respiratory Research

P1476

Soluble receptor for advanced ...... lmonale: a case-control study.

@en

P2093

Edo Fornai

http://www.w3.org/2001/XMLSchema#string

Franca Cocci

http://www.w3.org/2001/XMLSchema#string

Matteo Bottai

http://www.w3.org/2001/XMLSchema#string

P2860

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins

Genome-wide association study identifies five loci associated with lung function

Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function

Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control

S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB

Standardisation of the single-breath determination of carbon monoxide uptake in the lung

Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types

A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis

P2888

1465-9921-12-37

P304

37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1465-9921-12-37

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Massimo Miniati

Giuseppina Basta

Simonetta Monti

P577

2011-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50935624

http://www.w3.org/2001/XMLSchema#string

P6179

1017899165

http://www.w3.org/2001/XMLSchema#string

P698

21450080

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

3072955

http://www.w3.org/2001/XMLSchema#string